Patent assignee · US · COMPANY

ORPHAGEN PHARMACEUTICALS

2Patents
2Active
2Granted
41Portfolio score

Filing activity: May 24, 2011 → Feb 13, 2013 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8389739B1 Modulators of retinoid-related orphan receptor gamma Chemistry; Metallurgy 40 Active
US9657053B2 Modulators of retinoid-related orphan receptor gamma Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.